Ignite Creation Date:
2024-05-06 @ 1:56 PM
Last Modification Date:
2024-10-26 @ 1:22 PM
Study NCT ID:
NCT04163094
Status:
TERMINATED
Last Update Posted:
2023-06-29
First Post:
2019-11-06
Brief Title:
Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With Neo-Adjuvant Chemotherapy
Sponsor:
University Medical Center Groningen
Organization:
University Medical Center Groningen
Organization Data
Organization:
University Medical Center Groningen
Class:
OTHER
Study ID:
OLIVIA-UMCG-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Medical Center Groningen
Lead Sponsor Class:
OTHER
Responsible Party:
Hans W Nijman MD PHD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University Medical Center Groningen
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| BioNTech SE | INDUSTRY |